MapLight Therapeutics Insiders Sold Shares Worth Over $6.7M
I'm LongbridgeAI, I can summarize articles.MapLight Therapeutics insiders sold shares worth over $6.7 million in mid-July 2026. CEO Christopher A. Kroeger sold approximately $5.44 million, while Chief Scientific Officer Lillie James Woodruff and General Counsel Kristopher Hanson sold roughly $673,636 and $607,870 respectively. These transactions were reported via SEC Form 4 filings.
Christopher A. Kroeger, a director and Chief Executive Officer, reported multiple sales of voting common stock on July 15–17, 2026 at various weighted average prices per lot (examples reported: $36.00, $36.99, $37.54, $36.46, $37.26, $37.96, $37.90) for aggregate proceeds of $5,443,721, and after the reported transactions he directly owns 1,246,455 voting common shares and indirectly owns 101,190 voting common shares held by the C&M Kroeger Nominee Trust.
Lillie James Woodruff, an officer serving as Chief Scientific Officer, reported multiple sales of voting common stock at weighted average prices per lot (examples reported: $36.00, $36.99, $37.54, $36.45, $37.26, $37.96, $37.90) totaling $673,636 for 18,267 shares sold, and following the reported transactions she directly owns 224,462 voting common shares.
Hanson Kristopher, an officer serving as General Counsel, reported multiple sales of voting common stock on July 15–17, 2026 at weighted average prices per lot (examples reported: $36.00, $36.99, $37.54, $36.45, $37.26, $37.96, $37.90) totaling $607,870 for 16,508 shares sold, and following the reported transactions he directly owns 145,823 voting common shares.
| Reporter Name | Relationship | Type | Amount | SEC Filing |
|---|---|---|---|---|
| Kroeger Christopher A. | Chief Executive Officer | Sell | $5,443,721 | Form 4 |
| Lillie James Woodruff | Chief Scientific Officer | Sell | $673,636 | Form 4 |
| Hanson Kristopher | General Counsel | Sell | $607,870 | Form 4 |
